Before the market open, the Bloomfield, CT-based health insurance provider reported adjusted earnings of $1.94 per share, topping Wall Street's estimates of $1.90 per share, according to FactSet.
Revenue rose 5% to $9.88 billion over last year and was above the FactSet consensus of $9.87 billion.
For the full year, Cigna forecasts adjusted earnings per share between $7.80 and $8.05. Analysts surveyed by FactSet are modeling adjusted earnings of $7.98 for the year.
Cigna expects full-year revenue to grow in the mid-single digit percent range year-over-year. In 2015, the company generated $37.82 billion in revenue.
Wall Street is projecting revenue of $39.70 billion for 2016, according to FactSet.
The company is currently seeking regulatory approval for its proposed $54.2 billion deal with health insurance provider Anthem (ANTM).
Cigna stock closed higher on Wednesday.
Separately, TheStreet Ratings objectively rated this stock according to its "risk-adjusted" total return prospect over a 12-month investment horizon. Not based on the news in any given day, the rating may differ from Jim Cramer's view or that of this articles's author.
TheStreet Ratings rated Cigna stock as a "buy" with a ratings score of B.
The company's strengths can be seen in multiple areas, such as its revenue growth and largely solid financial position with reasonable debt levels by most measures. We feel its strengths outweigh the fact that the company has had sub par growth in net income.
You can view the full analysis from the report here: CI